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ABSTRACT
The endosome-disrupting and pH-responsive poly(2-diethylamino ethyl methacrylate)-core/poly(2-
aminoethyl methacrylate)-shell nanoparticles could potentially increase the efficacy of transcutaneous
administered vaccines and facilitate the cytosolic delivery of a wide variety of therapeutic
macromolecules.
One of the goals of this study was to reduce the size of these core-shell nanoparticles to improve their
permeation into the skin. Separate nanoparticle syntheses using reduced durations, decreased
monomer concentrations, and decreased monomer solubility did not cause a significant decrease in the
particle diameter compared to those previously reported. Manipulation of the reaction kinetics did not
stabilize smaller particles leaving them susceptible to coagulation. Synthesis of poly(2-diethylamino
ethyl methacrylate)/ Poly(ethylene glycol) methacrylate copolymer nanoparticles were sterically
stabilized by the amphiphilic polymer brush at the particle surface and exhibited slightly smaller
hydrodynamic diameter measured by dynamic light scattering. Manipulation of the reaction kinetics
and the monomer ratio could lead to significantly smaller chains.
Another goal for this study was to create core-shell nanoparticles with different charged shells to see if
the shell could be modified to electrostatically adsorb a wider range of drugs. In addition, the different
charges of the shell could affect the nanoparticles' endosome-disrupting abilities and/or their
permeation through the skin. Surprisingly, the zeta-potential measurements were the same for each
sample though the shells were supposed to have different charges. This suggests that surface charge
density of the PDEAEMA core was being measured. When nanoparticles with a smaller PDEAEMA core
and a thicker PAEMA shell were synthesized, a change in the zeta potential was observed that was
consistent with the larger positive surface charge density and the higher pKb of the PAEMA shell. This
suggests that the adsorption of positively charged drugs may be difficult because it would require
negatively charged shell that is thick enough to counteract the positive PDEAEMA core.
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Introduction
Several new strategies have been developed that could potentially treat and/or prevent some of
the world's most lethal diseases; however, they require the delivery of specific macromolecules into the
cytoplasm or nucleus of their target cells. Some of these strategies could involve stimulation of adaptive
immunity using synthetic vaccines,' tumor suppression using cell-specific toxins, 2 gene transfection
using plasmid DNA,3 and gene silencing using siRNA.4 In particular the stimulation of an adaptive
immune response is an attractive strategy because it utilizes the body's own defense mechanism and
can be applied to both treat and prevent a variety of infectious diseases and even cancer.
One mechanism for the initiation of adaptive immunity involves the uptake of synthetic vaccines
or antigens by dendritic cells (DC) because they are antigen-presenting cells that are proficient in
activating naive T cells.5 Antigens that reach the DC cytosol are presented much more effectively to
CD8+ cytotoxic T cells because they are brought to the cell surface efficiently by the class I major
histocompatibility complex molecules.6 However, many of the potential drugs and vaccines are
membrane-impermeable making it difficult for them to enter the cytosol without being deactivated.
Membrane-impermeable macromolecules normally enter the cell via endocytosis, macropinocytosis, or
phagocytosis, all of which compartmentalize the macromolecules in closed vesicles, lower the pH, and
digest the foreign entity. As a result, there has been significant amount of research investigating
potential vectors for the transport of hydrophilic molecules into the cell's cytoplasm. 7
A promising mechanism for the cytosolic delivery of membrane-impermeable molecules utilized
pH-responsive core-shell nanoparticles to disrupt the endosome and disperse the drug throughout the
cell." These vector nanoparticles were synthesized using a two-stage surfactant-free emulsion
polymerization; the first stage involves the polymerization of 2-diethylamino ethyl methacrylate
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(DEAEMA) cores crosslinked by poly(ethylene glycol) dimethacrylate (PEGDMA, MWPEO = 200 g/mol),
and the second stage entails the addition of the 2-aminoethyl methacrylate (AEMA) shell (Figure 1).8
extracellular/cytosolic pH endolysosomnal pH
pH-sensitive core Crosslinker Shell
0 a 0, O
H2C.. I C--' HN 1 ,... ." 2zJL
I H2 ZH2
Diethylamino ethyl methacrylate Poly(ethylene glycol) dimethacrylate
(DEAEMA) (PEGDMA) Aminoethyl methacrylate (AEMA)
Figure 1. Schematic of the pH-sensitive core-shell structure and the key chemical ingredients. Core-shell
nanoparticles are synthesized using a 2-stage surfactant-free emulsion polymerization.
The protonization of the tertiary amine of the DEAEMA monomer (pKb = 7.0 - 7.3) causes the
PDEAEMA cores to experience a significant increase in particle size near neutral pHs. The PEGDMA
crosslinker fortifies the network of the weak polybase chains associated with a hydrogel and provides
long-term particle stability (> 1 week in neutral saline).8 The primary amine of the AEMA monomer (pKb
~ 11) causes the PAEMA shell to be protonated across the relevant range: from physiological pH (7.4) to
endosomol pH (> 4.5). As a result, the charged PAEMA shell encapsulates the cytotoxic PDEAMA core
and facilitates electrostatic drug adsorption to the particle surface.
The core-shell nanoparticles have been demonstrated to be able to enter the cells through
endocytosis/phagocytosis and disrupt the endosomes via the proton sponge effect facilitating the
cytosolic of delivery of the model protein antigen, ovalbumin (OVA). As the pH drops within the
endosome, the increased protonization of the tertiary amines within the PDEAEMA cores provides the
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particles with a buffering capacity in addition to the swelling characteristics. To maintain neutrality,
chloride ions are transported within the endosome along with the acidifying protons. The PDEAEMA
cores within the endosome soak up the influx of protons letting the chloride ions accumulate in the
closed vesicle. As a result, the core-shell nanoparticles prevent the adsorbed drug molecules from being
denatured by preventing the drop in pH. In addition to the particle swelling, the osmotic swelling due
to the chloride accumulation causes the endosome to burst, which is known as the proton sponge
effect.9 The cytosolic delivery of OVA by the core-shell nanoparticles has also been demonstrated to
elicit a functional downstream response in CD8 cytotoxic T cells. After the coincubation of OVA-loaded
nanoparticles with bone marrow-derived DCs, cytosolic delivery of OVA was observed in ~ 43% of the
cells and a 4-fold increase in naive CD8 T cell activation compared to controls.
Besides the fact that that the pH-sensitive core-shell nanoparticles facilitated cytosolic delivery of
the membrane-impermeable and initiated an adaptive immune response through the activation na'lve
cytotoxic T cells, this drug delivery system also seems promising because the composition of the shell
can be manipulated separately from the endosome-disrupting core to accommodate a variety of
different drugs and to target specific cells. In addition, the core-shell nanoparticles have the potential to
improve transcutaneous administration of vaccines. Transcutaneous delivery of the these core-shell
nanoparticles would not only eliminate the need for syringes but would also increase drug efficacy due
to the efficient antigen uptake by Langheran dendritic cells.10 However, particle penetration into skin is
limited by the barrier created by the outermost layer of the epidermis, the stratum corneum. While
several strategies have been demonstrated to improve transcutaneous vaccine administration, there
have not been any practical transcutaneous vaccines yet. Polylactide-co-glycolide microspheres have
been successfully administered transcutaneously using an optimized topical formula that improved
particle penetration; however, particle penetration was found to decrease with increasing particle size.1
The pH-responsive core-shell nanoparticles have the potential to facilitate cytosolic delivery of a
variety therapeutic macromolecules, which could improve the effectiveness of transcutaneous vaccines.
Our first goal was to synthesize smaller particles so that they could achieve a larger degree of
transcutaneous penetration, and our second goal was to synthesize particles with different charged
shells to see whether it affects the breadth and types of drugs that could be elecbound We focused on
reducing the diameter of the PDEAEMA core without the PAEMA shell because the core provides the
most significant contribution to the core-shell particle size. We tried to reduce the core size by reducing
the synthesis duration, reducing the DEAEMA concentration, decreasing the monomer solubility by
increasing the synthesis pH, and sterically stabilizing the particles with an amphiphilic comonomer,
poly(ethylene glycol) methacrylate (PEGMA, MWPEO= 1000 g/mol). When we reduced the synthesis
duration and monomer concentration, we observed smaller PDEAEMA core diameters; however, using
the same reaction conditions our particles were typically larger than the previously characterized
particles. In order to achieve significantly smaller particle diameters, the small particles most likely
require another mechanism for particle stabilization rather than just electrostatic repulsion. To observe
whether the shell is actually tunable to provide drug payload flexibility, PDEAEMA cores were
synthesized with a polar PEGMA shell, a negatively charged methacrylic acid/PEGMA shell, and a
positively charged AEMA/PEGMA shell. In addition, the different charged shells could also affect the
endosome-disrupting ability and/or their permeability through the skin. Surprisingly, the particles with
the different charged shells all exhibited similar zeta potentials measurements, which most likely
reflected the surface charge density of the PDEAEMA core. When we synthesized nanoparticles with a
smaller PDEAEMA core and a thicker PAEMA shell, we were able to observe a change in the zeta
potential that was consistent with the larger positive surface charge density and the higher pKb of the
PAEMA shell. This suggests that the adsorption of positively charged drugs may be difficult because it
would require negatively charged shell that is thick enough to counter the positive PDEAEMA core.
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Experimental Methods
Materials
2-diethylamino ethyl methacrylate (DEAEMA, 99%), 2-aminoethyl methacrylate hydrochloride (AEMA,
90%), methacrylic acid (MAA, 99%), and ammonium peroxodisulfate (APS) were purchased from Sigma-
Aldrich Chemical Co. Poly(ethylene glycol) dimethacrylate (PEGDMA, MWPEO = 200 g/mol) and
poly(ethylene glycol) methacrylate (MWPEO = 1000 g/mol) were purchased from Polysciences Inc.
Synthesis of pH-sensitive core-shell nanoparticles
DEAEMA (1mL, 4.97mmol) and PEGDMA 200 (10[iL, 0.03mmol) were mixed in an eppendorf tube before
being dispersed in 9 ml. The reaction mixture was stirred with a magnetic stir-bar and equilibrated at
70°C for 15min before adding the APS (501L of 200mg/mL freshly made solution) initiator. The synthesis
reaction was allowed to run for 3 hrs at 70'C to grow the PDEAEMA particle core. At the end of the 3 hr
core synthesis, AEMA (501L of 800mg/mL freshly made solution, 0.24mmol) was injected into reaction
mixture to grow the particle shells for an additional 1.5 hrs. The nanoparticles were purified by dialysis
(10,000 MWCO Slide-A-Lyzer® Dialysis Cassettes, Pierce Chemical Co.) in 4 L of deionized water for three
days followed by three sets of washing by centrifugation (15,000xg for 15 min) and pellet resuspension
in PBS (pH 7.4). Purified particles were stored in PBS at 4°C.
Syntheses for reduced particle size
Five different synthesis reactions of PDEAEMA cores were allowed to polymerize for different
durations (~3 min, 30 min, 60 min, 90 min, and 180 min). After adding the APS to the reaction mixtures,
each sample was maintained at 700C and stirred for the appropriate period before removing them from
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the hotplate. For the ~3 min sample, after adding the initiator, reaction mixture was removed from the
hotplate as soon as synthesis reaction turned milky. Once the sample was removed from the heat
source, they were immediately injected into a dialysis cassette and placed in a stirred beaker containing
4 L of deionized water.
PDEAEMA cores were synthesized using four different monomer/crosslinker concentrations and
otherwise the procedures were the same as those outlined on pg. 5 for the synthesis of the pH-sensitive
core-shell nanoparticles except for the addition of the AMEMA shell. The first sample used 1 ml
DEAMEA (4.97 mmol) and 10 pl PEGDMA (0.03 mmol). The second sample used 0.75 ml DEAEMA (3.73
mmol) and 7.5 pl PEGDMA (0.023 mmol). The third sample used 0.50 ml DEAEMA (2.49 mmol) and 5 pl
PEDGDMA (0.015 mmol). The fourth sample used 0.25 ml DEAEMA (1.24 mmol) and 2.5 pl PEGDMA
(0.008 mmol).
For two PDEAEMA core syntheses, 7.5 pl 1 M NaOH was added to the 9 ml of deionized water
prior to the addition of the monomer/crosslinker. The resulting pH was measured to be ~8 using a pH
test strip. One reaction was allowed to run for the full 180 min, while the other sample was placed in
the dialysis cassette after "3 min. Otherwise, the reaction conditions were the same conditions for the
synthesis of the pH-sensitive core-shell nanoparticles described on pg. 5.
Synthesis of PDEAEMA/PEGMA copolymer nanoparticles
Equal weights of DEAEMAA (0.5 mL) and PEGMA 1000 (0.461 g) were combined in 9 ml
deionized water for three synthesis reactions with different SDS surfactant concentrations (No SDS, 20
mg SDS, and 200 mg SDS). No crosslinker was added to any of the three reactions. Otherwise, the we
followed the same procedure for the synthesis of the pH-sensitive core-shell nanoparticles.
Syntheses for nanoparticles with different shell compositions
Nanoparticles with three different shells were synthesized (PEGMA, MAA/PEGMA, and
AEMA/PEGMA). For each sample, we added an additional 0.5 pl of PEGDMA with the shell, and we used
the same total mass for the shell components as we did for the shell in the synthesis of the pH-sensitive
core-shell nanoparticles (40 mg). The conditions for the PDEAEMA core synthesis were the same as the
synthesis of the pH-sensitive core-shell nanoparticles described on pg. 5. For the PEGMA shell sample,
we added 36.36 [a PEGMA 1000 to reaction at the end of the 3 hour core synthesis and allowed the
polymerization of the shell to proceed for an additional 1.5 hours. For the MAA/PEGMA and
AEMA/PEGMA samples, we used a 2:1 ratio by weight of PEGMA to MAA or AEMA. For the
MAA/PEGMA shell we added 24.24 il PEGMA 1000 and 13.14 [l of MAA. For the AEMA/PEGMA shell,
we added 24.24 Il PEGMA 1000 and 13.33 mg AEMA.
Synthesis of Nanoparticles with Shells of Different thicknesses
The thin AEMA shell sample was synthesized following the exact same procedures outlined in
the synthesis of the pH-sensitive core-shell nanoparticles on pg. 5. We followed the same procedure for
the thicker shell except we used different concentrations for the core/shell monomers, initiator, and
crosslinker. To make the core smaller we added only half of the original weights of the reagents used
for the core synthesis (0.5 ml DEAEMA, 5 l of PEGDMA, and 100 mg APS initiator) to the 9 ml of
deionized water. To make the shell thicker we used 4.5x the original weight of AEMA monomer (180
mg) and we added additional crosslinker (2.3 aIl PEGDMA).
Dynamic light scattering measurements of particle size distributions and zeta potential
Dynamic light scattering measurements of the particle size distributions were made using 90Plus
particle size analyzer from Brookhaven Instruments Corporation. For the instrument parameters we
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conducted 6 runs for 30 seconds using a refractive index of 1.5, a dust cutoff of 30, and a 900 scattering
angle at 250C. For sample preparation, 5 ili of the purified nanoparticle suspension was diluted in 150 -
500 pl of appropriate pH 100 mmol PBS buffer so that the countrate was between 100 and 700 kcps.
Particle size measurements were repeated for each sample diluting them in each of the different pH 100
mmol PBS buffers (pH 4.83 - 8.17).
For the zeta potential measurements, the zeta potential utilizing phase analysis light scattering
(ZetPALS) from Brookhaven Instruments Corporation was used. Because the concentration of our
samples was not measured, the particle concentration was assumed to be on the order of 0.01 mg/ml.
For sample preparation, 40 l of purified sample was added to 6 ml of 5 mM NaCI solution. Then the pH
of the solution was adjusted using 0.1 M NaOH or 0.1 M HCI to the desired pH. The zeta potential
measurements were then repeated for several different pH environments (5.13 - 9.76).
Results and Discussion
The Effect of the PAEMA Shell on the PDEAEMA Core pH Sensitivity
Because the PDEAEMA core is the most significant contributor to the diameter of the core-shell
nanoparticles, the PDEAEMA core was the primary target for the reduction in particle size. In order to
eliminate the variations in particle size due to the thickness of the PAEMA shell, PDEAEMA cores were
mainly synthesized without the addition of the shell. Therefore, the pH sensitivity of the nanoparticles
with a PAEMA shell was compared to PDEAEMA core without a shell. Figure 2 shows the hydrodynamic
diameters for PDEAEMA nanoparticles with and without the PAEMA shell measured by dynamic light
scattering in phosphate buffered saline solutions with pHs ranging from 5.97 to 8.17.
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Figure 2. pH responsive swelling for PDEAEMA cores with and without the PAEMA shell. The data points reflect
DLS measurements of the hydrodynamic radius for the samples in 100 mmol PBS buffers of various pHs after
dialysis and centrifugation washing. The synthesis of the DEAMA cores were the same for both samples. The
sample with the shell had 0.24 mmol freshly made AEMA injected after core synthesis and was allowed to grow for
an additional 1.5 hours
The presence of the PAEMA shell was not found to alter the measured particle diameter significantly.
However, the degree of swelling was observed to be larger for the particles without the PAEMA shell
compared to the particles with the shell (2.5 fold increase compared to 2.0 fold increase). These
observed pH dependent swellings are comparable to the 2.8 fold increase previously reported for the
core-shell nanoparticles synthesized under the same conditions. While the core-shell nanoparticles
were previously observed to swell from about 200 nm to 550 nm over the pH range of 9.5 to 4.9, our
core-shell nanoparticles swelled from about 230 nm to 450 nm over the pH range of 8.17 to 5.97. The
nanoparticles without the shell swelled from 194 nm to 486 nm over the same pH range. The particles
lacking the shell could have demonstrated a larger degree of pH sensitivity because they are not
constrained by the pH insensitive shell. In addition, the particles lacking the shell also seemed to display
the swelling transition at a lower pH. This could be a result of some interaction of the PAEMA shell with
the additional protons or experimental error. Nonetheless, for the purposes of this experiment we
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determined that the PAEMA core does not significantly affect the particle size across the relevant pHs
and that the size of DEAEMA core needed to be reduced in order to produce smaller core-shell
nanoparticles.
The Effect of Synthesis Duration on Particle Size
Our first attempt to reduce the diameter of the pH-responsive PDEAEMA cores involved the
reduction of the synthesis duration to limit particle growth. After the creation of a polymer phase due
to particle nucleation, chain propagation occurs at higher rate within the polymer phase than the
aqueous phase (due to the limited solubility of the monomer), which causes the particles to grow over
time.1 By terminating the polymerization reaction at different times subsequent to the start of
polymerization, we were able to manipulate the size pH-sensitive PDEAEMA nanoparticles. Figure 3A
demonstrates how the PDEAEMA nanoparticle cores that underwent shorter synthesis durations also
had smaller hydrodynamic diameters measured by dynamic light scattering. Measurements for each
sample were repeated in phosphate buffered saline solutions with pH's varying from 4.83- 8.17 in order
to observe the nanoparticles' pH sensitivity.
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Figure 3. pH-responsive swelling of PDEAEMA cores with varying synthesis durations. (A) Hydrodynamic
diameters of syntheses allowed to run for 30 - 180 minutes in 100 mmol PBS buffers with various pHs measured
by DLS. (B) Hydrodynamic diameters of syntheses allowed to run for 3 minutes and 180 minutes in 100 mmol PBS
buffers with various pHs measured by DLS. Samples underwent dialysis and centrifugation washing prior to DLS
measurements.
We observed that the particle size grew exponentially with elapsed synthesis time for each
measurement pH (Figure 3A). This trend is not consistent with the findings of Goodall et al. (1977), who
reported a parabolic rate law of the form: (size)2 = Ct for emulsion polymerizations of polystyrene
nanoparticles without any added surfactant.13 They modeled this growth rate by assuming that the rate
limiting event during particle growth was the diffusion of monomer/oligomer into the polymer particles
and determined that average number of propagating free radicals within the particles was increasing
with particle size. Goodall et al. (1977) setup the polystyrene polymerization reactions using similar
conditions (0.870 M styrene, 3.7 x 10-3 M potassium persulfate initiator, 70 0 C synthesis temperature, no
cross-linker); however, rather than stopping the entire reaction, they used large reaction vessels (2 or 4
dm3 ) and removed small samples for analysis at various times. In addition, they only measured
dehydrated particle sizes using TEM by sampling at least 250 particles. The difference in the observed
growth rate could be because of the difference in the polymer system (styrene vs. DEAEMA), the
_ 
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different time ranges for particle measurements, or the different procedures for terminating the
synthesis reaction.
The difference between the exponential growth rate we observed and the parabolic rate
reported by Goodall et al. (1977) was mainly due to the rapid particle growth they observed at small
times compared to the slow growth we observed. Although the different reaction kinetics at early time
points could be attributed to the different polymerization systems, we believed that the rapid growth
rate observed by Goodall et al. (1977) was because they included measurements at smaller times where
they could observe primary particles. In our experiment, there was no significant difference between
the samples that were allowed to react for 30 and 60 minutes; both demonstrated a 52% decrease in
particle diameter on average for all measured pHs compared to samples allowed to run for the full 3
hours (Figure 3A). At pH 8.17 (particles are condensed), the 3 hour synthesis had an average particle
diameter of 572.5 ± 7.9 nm with an average polydispersity of 0.123. At the same pH, the 30 minute and
60 minute samples had an average diameter of 257.2 ± 2.9 nm and 248.5 ± 0.4 nm respectively with an
average polydispersity of 0.16 and 0.006 respectively. When we repeated the PDEAEMA synthesis for
an even shorter time (about 3 minutes), the observed particles were on average 60% smaller for all
measured pHs than the particles allowed to run for the full 3 hours (Figure 3B). At pH 8.17, the 3 hour
synthesis had an average diameter of 392.4 ± 1.9 nm with an average polydispersity of 0.095. At the
same pH, the 3 minute synthesis had an average diameter of 141.2 + 0.9 nm with an average
polydispersity of 0.004. It should be noted that the 3 hour control synthesis in Figure 3b produced
particles that were on average 37% smaller for all measured pHs than the particles produced by the 3
hour synthesis in Figure 3A. In addition, we could not identify any clear trend when comparing the
polydispersity of the particles versus time; all the synthesized particles were found to be monodisperse
with a polydispersity less than 0.2 measured by DLS (data not shown). However, it should be noted that
DLS is not considered to provide reliable polydispersity measurements. 14 Although the 3 minute
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synthesis was comparable to the duration where Goodall et al. (1977) and others reported to have
observed primary particles, we were not able to observe a significant decrease in particle size associated
with primary particles compared to the 30 minute and 60 minute syntheses. We believe that we did not
observe significantly smaller particles after the 3 minute synthesis because primary particles are
colloidally unstable, which makes them susceptible to coagulation. The coagulation of smaller particles
could also explain why there was not much of a difference between the sizes of the particles that ran for
30 min compared to the particles that ran for 60 min.
Assuming that we were not able to measure primary PDEAEMA particles, we compared our
procedure for terminating the synthesis reactions to the procedure employed by Goodall et al. (1977) in
order to determine why we were unable to prevent coagulation. After experiencing some difficulties
using hydroquinone to inhibit polymerization, Goodall et al. (1977) adopted a technique in which they
immediately diluted the sample (1:100) and stored them at 150 C. With these conditions, they claimed
to have observed 5-10 nm or larger primary particles after about 5 minutes, which rapidly increased in
size and became monodisperse after about 30 minutes. We followed a similar procedure. Because we
conducted smaller scale synthesis reactions, we removed the entire sample from the heat source and
transferred the turbid solution into a dialysis cassette to be placed in about 3 liters of MilliQ deionized
water at room temperature (about 250 C) after the desired synthesis period. Our particles could have
coagulated because we did not dilute the samples immediately after removing them from the heat
source or because we did not store them in a cold enough environment. In addition, thermal
termination of the polymerization reaction might not provide a precise method for identifying the small
initial particles. By cooling the samples, we reduce or eliminate the decomposition of initiator into free
radicals, but this does not eliminate the free radicals that already exist throughout the system. After the
samples have been removed from the heat source, there may be some additional time for
polymerization before the free radicals terminate in the aqueous or polymer phases. In addition, there
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could also be some residual initiator decomposition after the samples are removed from the heat source
due to variations associated with the cooling rate of the samples. However, we believe that the most
likely cause of particle coagulation was the conditions for centrifugation washing. Small particles could
be colloidally stable because we used an amphiphilic crosslinker, some of the chains ends could posses a
de-protonated sulfate group from the initiator at the particle surface, and the DEAEMA cores
themselves posses a tertiary amine with pKb of 7.0-7.3 (some of which would be protonated because the
reaction takes place in deionized water with pH ~ 5 prior to the addition reagents). According to DLVO
theory, which takes into consideration the potential energy of any two mutually approaching particles
due to van der Waals and electrical double layer interactions, the potential energy barrier of these
charged particles could be enough to stabilize the particles from aggregating due to Brownian motion.
This potential energy barrier depends on the concentration and nature of the electrolyte environment,
the particle size, and the surface-charge density. s Therefore, the centrifugation washing process
provides a serious threat to the colloidal stability of small particles. Following the procedure for
nanoparticle preparation described by Hu et al. (2007), we centrifuged the synthesis products 3 times at
15,000xg with PBS (pH 7.4) to remove any unused long polymer chains that could not be removed by the
10,000 MWCO dialysis cassettes. The centrifugation was conducted using 100mmol PBS (pH 7.4) in
order to mimic physiological conditions because of the potential drug-delivery applications. This process
was deemed necessary in order to remove the excess polymer chains that would potentially interfere
with DLS size measurements. However, the 100 mmol PBS solution provided an electrolyte environment
that could have diminished the potential energy barrier keeping the small particles isolated and the
centrifugation could have compacted the particles into a pellet forcing the particles to a much closer
proximity. As a result, we should either repeat these experiments without the centrifugation washing
step or at least try washing with deionized water as this process greatly increases the chances of
coagulation. In addition, the DLS size measurements using basic PBS buffers could also promote
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coagulation of smaller particles. The pKb of the tertiary amine in the PDEAEMA core is 7.0 - 7.3;
therefore, the DLS measurements for the condensed particles at basic pHs reduce the degree of
ionization of the DEAEMA monomers, which, in turn, decreases the zeta potential. The reduced
electrostatic repulsion between neighboring would greatly increase the chance for particle coagulation
due to Brownian motion.
We also observed variations in the sizes measured for the particles created using the previously
established reaction conditions. The 180 minute synthesis samples were synthesized and measured by
DLS following the experimental procedures described by Hu et al. (2007) (except for the additional
polymerization step for the AEMA shell); however, in Figure 3A, our particles measured twice as large
over the same pH range. For the full 3 hour synthesis, Hu et al. (2007) reported a diameter of around
210 nm determined by DLS at 25 OC in PBS buffer with pH 8.07 and physiological ionic strength.
Following the same procedures, our particles were found to have average diameter of 572.5 ± 7.9 nm
(Figure 3A) and 392.4 ± 1.9 nm (Figure 3B) when the reaction was allowed to run for the full 3 hour
period. These differences could be attributed to procedural errors. For example, hydrophobic
monomer droplets were kept dispersed in the deionized water by stirring using small cylindrical
magnetic stir bars. Some stir bars were found to have more stable rotations than others at the rotation
speed required to disperse the monomer droplets. In particular, some of the stir bars could not be
maintained so that they only rotated about one axis; some would revolve around the bottom of the 15
ml vial as they rotated. As a result, the variable mixing conditions also could have contributed to the
variations observed for repetitions of the synthesis reactions with the same setup conditions. In
addition, both procedures did not include the deionized water containing the monomer and crosslinker
being sparged with nitrogen prior to the addition of the initiator. When we attempted to sparge the
samples, the tubing that would bubble the nitrogen would prevent us from establishing stable rotations
for some of the stir bars that kept the monomer dispersed. Because the samples were not provided
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with an inert environment, daily differences in atmospheric pressure and humidity could produce
variations in the concentration of oxygen within the synthesis environment, which would produce
variations in the amount of free radical termination. We decided that variation in particle size due to
poor stirring was more significant than the variations due to atmospheric oxygen fluctuation and radical
termination.
The Effect of Monomer Concentration on Particle Size
Because the rate of particle nucleation and particle growth have both been found to depend on
monomer concentration, we decided to see if we could decrease the particle size by reducing the
monomer concentration. 16,17.The Fitch-Tsai equation provides a qualitative tool for understanding the
key processes that determine the rate of nucleation in emulsion polymerization:16
j= R; R R (1)
where N is the number of particles per liter (dm-3), Ri, is the rate of chain initiation in the aqueous
phase, b is scaling factor that takes into account the fact that not all radicals lead to propagation due to
side reactions, Rc is the overall average rate of oligoradical capture by particles, and Rf is the overall
average rate of coagulation.'" The particle nucleation rate has a strong dependence on monomer
concentration because Rw depends on the concentration of monomers available for chain initiation and
Rc depends on the concentration of oligomeric radicals (which also depends on the concentration of
aqueous monomers) that can be captured by the particles for particle growth. The nucleation rate
becomes important in determining the particle size because there is limited amount of radicals and
monomer. Conservation of mass dictates that the greater the number concentration of nucleated
particles, the smaller the monomer concentration in the polymer phase; thus, larger nucleation rates
tend to produce smaller particles. 16 18 However, the particle coagulation rate provides an additional
competing process that also governs particle size. Verwy and Overbeek (1948) created a model for the
particle coagulation based on Smoluchowski and Fuchs' and DLVO theories in which the particle
coagulation rate depends on the square of the number concentration of particles. Finally, the monomer
concentration also affects the particle size distribution because it governs particle growth after
nucleation. Growth from the propagation of polymer chains within the particles depends on the
concentration of monomers and the concentration of propagating radicals within the polymer particles.
In light of these competing processes that determine particle size, we found that the particle size
decreased with decreasing monomer concentrations. Figure 4 demonstrates how the hydrodynamic
diameters of PDEAEMA nanoparticle cores measured by dynamic light scattering decreased with
decreasing total initial monomer concentration. The control sample (4.97 mmol DEAEMA, 0.03 mmol
PEGDMA) was synthesized following the protocol described by Hu et al. (2007) except for the addition of
AEMA shell. Parallel PDEAEMA core synthesis reactions were conducted in following the same
procedure except the initial monomer and cross-linker concentrations were decreased. In each
synthesis, the molar percent of crosslinker to monomer was maintained at 0.6% in order to eliminate
any variation in particle diameter due to the degree of crosslinking. Measurements for each sample
were repeated in phosphate buffered saline solutions with pH's varying from 6.96- 7.82 in order to
demonstrate that the nanoparticles still maintained their pH sensitivity.
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Figure 4. pH-responsive swelling of PDEAEMA cores synthesized with various monomer contents. Hydrodynamic
diameters in 100 mmol PBS buffers with various pHs measured by DLS. Monomer:Crosslinker molar ratio was
maintained for each sample. Each sample had 0.04 mmol APS.
We observed a logarithmic dependence between monomer content (molH2o/ moIDEAEMA) and the
hydrodynamic radius of the synthesized PDEAEMA core nanoparticles. This observation is consistent
with the linear decrease in hydrodynamic particle diameter observed by Wutzel and Samhaber (2007)
when they decreased the initial concentration of styrene monomer in the emulsion polymerization of
polystyrene nanoparticles using SDS as a surfactant.19 It should be noted that because Wutzel and
Samhaber (2007) a surfactant, they observed a constant particle number concentration with varying
monomer content; therefore, they attributed the decrease in size to the decreased supply of monomer
from the droplets to the initiated micelles. Although we did not use a surfactant, the PEGDMA
crosslinker is amphiphilic and could form micelles to initiate polymer particles. We did not measure the
particle number concentration for our synthesis reactions, but the similar trend for particle size versus
monomer content suggests that the initial monomer content might not have a significant effect on the
particle number concentration for our surfactant-free system. Because all of our particles were found to
be monodisperse by DLS (data not show), this suggests that the initial period for stable particle
formation should be small. 16 Therefore, it is conceivable that the particle number concentration would
not change significantly with varying initial monomer content if instead the initial rate of particle
nucleation depends on the solubility of the monomer (which governs [M]w) and the initiator
concentration (which remained constant).
We observed an 32% average decrease across the entire pH range (6.96 - 7.82) for the
nanoparticles synthesized using a 5-fold decrease in monomer content (1.00 mmol DEAEMA and 7.5 x
10.3 mmol PEGDMA) compared to the nanoparticles synthesized following the protocol reported by Hu
et al. (2007), which used 4.97 mmol DEAEMA and 0.03 mmol PEGDMA. When the particles were
measured in 100 mmol PBS pH 6.96, our particles synthesized following Hu et al. (2007)'s protocol had a
hydrodynamic diameter of 561.7 ± 10.1 nm while the particles synthesized using a 5-fold decrease in
monomer content had a hydrodynamic diameter of 339.9 ± 1.9 nm measured by DLS. Using the same
synthesis conditions, our particle sizes were larger again compared to those previously reported by Hu
et al. (2007) at the same pH, and the particles synthesized with the 5-fold decrease in monomer content
were 32% smaller. However, our particles exhibited a smaller degree of condensation when placed in a
basic environment (pH 7.82). At this pH, our particles synthesized following Hu et al. (2007)'s protocol
had a hydrodynamic diameter of 358.2 ± 2.7 nm while particles synthesized using a 5-fold decrease in
monomer content had a hydrodynamic diameter of 236.1 ± 3.2 nm. Compared to the ~ 2.4-fold change
in diameter reported by Hu et al. (2007) over the pH range 7.0 - 8.0, our particles synthesized under the
same conditions and the particles synthesized with the 5-fold decrease in monomer content exhibited a
1.6 and 1.4 change in diameter respectively over the pH range 6.96 - 7.82. The day to day variations in
hydrodynamic radius between experiments for the particles synthesized under the same conditions
were larger than the observed decrease in swelling; therefore, the observed decrease in diameter could
be a result of the procedural errors discussed above in the experiment with varying synthesis durations.
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The Effect of a Basic Synthesis Environment on Particle Size
Because the rate of particle nucleation and thus the particle number concentration depends on
the concentration of monomer in the aqueous phase, we wanted to see if we could reduce the particle
size by decreasing the DEAEMA solubility using a basic synthesis environment. The pH of the deionized
water previously used for particle synthesis had a pH of ~ 5. At this pH, almost all of the tertiary amines
of the DEAEMA monomer (pkb of 7.0 - 7.3) would be protonated; therefore, we chose to conduct a
synthesis in which we adjusted the pH of deionized water to a higher pH to reduce the amount of
protonated DEAEMA monomers. After adding the monomer and crosslinker to the deionized water, the
pH for the reaction mixture was measured to be 9.38, which suggests that the DEAEMA monomers
already absorbed a significant amount of H' ions from the aqueous environment. Therefore, we decided
to adjust the pH of the aqueous reaction environment to pH 8 using 7.5 pl 1 M NaOH prior to the
addition of monomer and crosslinker. Figure 5 shows the hydrodynamic diameters of the particles
synthesized in the basic environment for 180 minutes and 3 minutes measured by DLS in 100 mmol PBS
buffers from pH 5.97 to pH 8.17.
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Figure 5. pH-responsive swelling of PDEAEMA cores synthesized in a basic environment (pH 8). 7.5 ul of 1 M NaOh
was added to the water prior to the addition of monomers. Hydrodynamic diameters were measured in100 mmol
PBS buffers with various pHs by DLS.
The 3 minute samples were on average 57% smaller than the 180 minute samples across the
entire pH range, which is consistent with our findings in the synthesis duration experiment (Figure 3B);
however, the particles synthesized in the pH 8 aqueous environment had larger measured
hydrodynamic diameters. Particles synthesized in the basic environment were 36% larger for the 180
minute samples and 34% larger for the 3 minute samples compared to the particles from the synthesis
duration experiment in Figure 3B. The larger particles were most likely a result of the decreased
monomer solubility in the aqueous phase. Because the nucleation rate depends on the concentration of
monomer in the aqueous phase, the decreased monomer solubility would most likely decrease the
initial particle number concentration. This trend would still hold true regardless of the mechanism for
particle nucleation (i.e. precipitation of critical length polymer chain, particle growth in surface active
oligomeric radical micelles, or particle growth in amphiphilic PEGDMA micelles). Decreasing the particle
number concentration could lead to a larger distribution of particle sizes due to the fact that there
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would be a larger concentration of available monomers per particle. 6 This becomes significant when
you consider that the radicals and monomer have to cross the particle/water interface.1 8 In addition,
decreasing the monomer solubility in the aqueous solution could increase the monomer concentration
in the polymer phase. In support of this hypothesis, Ceska (1974) found that increasing hydrophobicity
of carboxylic monomer used in the surfactant free emulsion copolymerization of polystyrene
nanoparticles increased the nucleation rate and the number concentration of particles.20 They
demonstrated that the more hydrophobic carboxylic monomers diffused more rapidly to particle surface
stabilizing the particles against coagulation.20 Therefore, increasing hydrophobicity of the DEAEMA
monomer could increase monomer diffusion to the polymer particles, which would increase the rate of
particle growth. However, the diameters of the particles synthesized for 3 hours in the basic
environment were only slightly smaller than the particles synthesized for 3 hours under normal
conditions. This suggests that the increased size of the particles from the basic synthesis could be a
result of the procedural errors noted in the synthesis duration discussion section.
Particle Stabilization by PEGMA/DEAEMA Copolymerization
The surfactant-free aspect of the emulsion polymerization system reported by Hu et al. (2007) has
several advantages for the potential drug chaperone applications of the core-shell nanoparticles. The
addition of a surfactant to the emulsion process would hinder their industrial viability because of the
potential toxicity of common surfactants and the difficulties associated with their removal. 21
Nonetheless, we decided to conduct PDEAEMA emulsion polymerization with surfactant due to the
previous unsuccessful attempts to reduce particles size. Surfactant facilitated emulsion polymerization
commonly produces smaller particles because there surfactant micelles can capture initiated oligomer
radicals to form new particles at a faster rate and for longer periods. The increased number
concentration of surfactant stabilized particles leads to smaller sizes. Unsurprisingly, the particles
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synthesized with two different SDS surfactant concentrations (0.2 and 2 wt% of the total synthesis
reaction) and various synthesis conditions all precipitated upon purification by dialysis. Although the
additional stabilization provided by the SDS may have led to the synthesis of smaller particles, the
particles could not remain stable when the SDS was removed by dialysis, and the particles coagulated to
form a bulk polymer phase. Upon observing this phenomenon, we decided to try a different mechanism
for particle stabilization that utilized the increase in interfacial free energy associated with surfactant
removal. Using surfactant emulsion copolymerization of DEAEMA/PEGMA 1000, we hoped to produce
long polymer chains with equal mole fractions of DEAEMA and PEGMA monomers (randomly oriented)
that were water soluble due to SDS surface stabilization. Upon the removal of the surfactant, we
hypothesized that the chains would collapse to conceal the hydrophobic DEAEMA units with the
hydrophilic PEGMA counterparts producing polymer brush stabilized nanoparticles. Figure 6 shows the
hydrodynamic diameters of the DEAEMA/PEGMA nanoparticles formed without any crosslinker using
two different SDS concentrations (0.2 and 2 wt% of total synthesis reaction). The hydrodynamic
diameters were measured by DLS twice: once in 100 mmol PBS buffer pH 7.4 and then again after the
addition of 1 M NaOH to raise the pH to ~ 9.
300
2 50 .. . . .. .
S200
150 iS 8 0.2% SDS
.100 4 .. . 2% 5DS
50
0
100 mmol PBS (pH 7.4) PBS + 1M NaOH (pH ~ 9)
Figure 6. Hydrodynamic diameters of PDEAEMA /PEGMA copolymer nanoparticles synthesized with equal weights
of each monomers (0.461 g). Because of the small total volume of synthesized nanoparticles, the particles were
measured in the 100 mmol PBS buffers at pH 7.4 used for the centrifugation washing. The measurement was then
repeated after adjusting the pH to ~9 using 1 M NaOH.
Without any added surfactant, no copolymer nanoparticles were formed because the lack of
surface stabilization led to coagulation and precipitation. Interestingly, there was no change in particle
diameter for DEAEMA/PEGMA nanoparticles synthesized with a 2 wt% SDS concentration. This is most
likely because these nanoparticles contained a significantly smaller mole fraction of DEAEMA monomers
compared PEGMA monomers. This hypothesis seems reasonable because both the PEGMA monomers
and initiator are water soluble compared to the barely water soluble DEAEMA monomers; therefore the
PEGMA monomers most likely have a much larger polymerization rate. On the other hand, the
DEAEMA/PEGMA nanoparticles synthesized with a 0.2 wt% SDS concentration were smaller than those
synthesized with the larger SDS concentration and exhibited a 12% decrease in diameter when the pH
was increased from 7.4 to 9. The limited pH sensitivity of these particles suggests that they have a larger
mole fraction of DEAEMA monomers than the mole the particles synthesized with the higher SDS
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concentration. The surfactant concentration could alter the DEAEMA mole fraction in the copolymer
nanoparticles because a significant change in surfactant concentration could change the polymerization
rates for each monomer or even the primary locus for polymerization. The diameters for the 0.2 wt%
DEAEMA/PEGMA sample are slightly smaller than those observed by Hu et al. (2007) over the same pH
range.
It is important to note that the synthesis of the DEAEMA/PEGMA nanoparticles was not as
efficient as synthesis of the crosslinked DEAEMA nanoparticles in terms of the total volume of
synthesized nanoparticles. Using the same mass of DEAEMA monomers and the same synthesis
duration, the volume of the DEAEMA/PEGMA nanoparticle pellet was much smaller during the
centrifugation wash. The pellet volume was so much smaller that a different procedure was used in
order to measure the pH-sensitivity of the particles using DLS. The DEAEMA/PEGMA particle number
concentration was so small that dilution with the different pH PBS buffers decreased the DLS count rate
below the critical level for reliable size measurements. The steric stabilization provided by the polymer
brush structure of the PEGMA at the particle interface is could facilitate the creation of smaller, pH-
sensitive particles by decreasing the molecular weight of the surfactant stabilized chain. Future
experiments would include manipulating the reaction kinetics (i.e. synthesis time, monomer
concentration, initiator concentration etc.) and varying the proportions of DEAEMA and PEGMA
monomers to create lower molecular weight.
The results of the experiments in which we attempted to reduce the particle size suggest that
the manipulation of the polymerization kinetics is not the most practical method for obtaining
significantly smaller particles. Smaller particles obtained in this fashion are less stable because of their
reduced charge density, and they have no other mechanism to prevent coagulation except for
electrostatic repulsion. One future study would include reducing the monomer to crosslinker ratio;
however, this would not provide any additional stabilization for smaller particles, which would leave
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them susceptible to coagulation. We could increase the initiator concentration; however this would
most likely not significantly reduce the particle size. The increase in the rate of nucleation and the
particle number concentration generally leads to smaller particles, but the increased number of particles
would also increase the rate of coagulation. In addition, a larger initiator concentration would also
increase particle growth because of the increase in the polymerization rate, and the additional de-
protonated sulfate groups at the chain ends would not help stabilize the particles because they're
negatively charged. We could also try to use the PAEMA shell to stabilize smaller particles because it
would remain charged due to its high pKb; however, we would have to be careful not to add the shell
too early during the core synthesis because this could lead to a bimodal distribution from the synthesis
of PAEMA rich particles. Although we only tried SDS for the surfactant, other surfactants would most
likely fail to reduce the particle size because they would also be removed during dialysis, which could
lead to coagulation or precipitation. Even if we successfully synthesized smaller electrostatically
stabilized particles, the purification by centrifugation and the DLS measurements in the basic PBS buffers
would most likely cause them to become colloidally unstable, unless we provide the particles with an
alternative stabilization mechanism like steric stabilization. Manipulation of the polymerization kinetics
and the relative monomer fractions for PDEAEMA/PEGMA copolymer particles could be successful in
reducing the particle size; however, the polymer brush stabilizing the surface could interfere with
electrostatic drug binding. Additional mechanisms for the stabilization of small particles need to be
explored. Once we successfully synthesized significantly smaller molecules, future studies would include
measuring the drug binding capacity using fluorescent OVA, and incubating DC cell cultures with cy5-
labeled nanoparticles loaded with fluorescent OVA to compare the endosome-disrupting ability of the
smaller particles to those observed by Hu et al. (2007).
Synthesis of pH-Responsive Core-Shell Nanoparticles with Different Shell Compositions
Because the primary mechanism for loading drugs on the core-shell nanoparticles characterized by Hu et
al. (2007) is electrostatic adsorption, the particle surface charge governs the type, amount, and release
of the drugs that can be adsorbed. In particular, the PAEMA shell used by Hu et al. (2007) remains
positively charged across the pH range required for drug delivery, which would only adsorb negatively
charged drugs. Therefore, we wanted to synthesize core-shell nanoparticles using monomers that
would produce different charged shells to see whether this system could be manipulated for the
delivery of a wider variety of drugs. We created nanoparticles with three different shells: a positively
charged PAEMA/PEGMA shell, a negatively charged MAA/PEGMA shell, and a polar shell with just
PEGMA. Compared to the core-shell nanoparticles created by Hu et al. (2007), we used the same
procedure for PDEAEMA core synthesis, the same total mass of shell monomer, and the same shell
synthesis duration; however, we maintained a 2:1 (PEGMA:Charged Monomer) ratio by mass for the
positively and negatively charged shells and added additional crosslinker. Figure 7 shows the size and
zeta potential measurements using DLS for the core-shell particles with the different charged shells.
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Figure 7. DLS measurements of particle size and zeta potentials for the PDEAEMA cores synthesized with different
charged shells. (A) Hydrodynamic diameters of nanoparticles with different shells measured by DLS in100 mmol
PBS buffers at various pHs. (B) Zeta potential was measured for the nanoparticles with different shell using DLS in 5
mM NaCl solutions with various pHs adjusted by 1 M NaOH and 1 M HCI.
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The nanoparticles with PAEMA/PEGMA and MAA/PEGMA shells were about twice the size of those
reported Hu et al. (2007) across the same pH range. In addition we observed a smaller change in
particle diameter (1.65 for the PEGMA shell particles, 1.99 for PAEMA/PEGMA shell particles, and 2.26
for the PMAA/PEGMA shell particles). The increased size and decreased swelling could be the result of
the additional crosslinker added during the shell synthesis. The additional PEGDMA could have
increased the amount of crosslinked chains, which might increase the number of core/shell chains per
particle and decrease the separation between chains during particle swelling. Alternatively, the
diameters for the particles with the PAEMA/PEGMA and MAA/PEGMA shells were also similar to the
diameters measured for 3 hour samples in the synthesis duration and basic synthesis environment
experiments (Figure 3A and Figure 5). The consistent size difference between our particles suggests that
there could just be a systematic error in the way we reproduced Hu et al. (2007)'s nanoparticle
synthesis.
Interestingly, the particles with the PEGMA shell had a similar diameter to the particles with the
PAEMA/PEGMA and MAA/PEGMA shells in the condensed state at pH 8.17; however, in the swollen
state at pH 5.97, the PEGMA shell particles were an average of 22% smaller between both the
populations of particles with charged shells. Although PEGMA was added during the synthesis of each
shell type, the decreased swelling for the particles with only the PEGMA shell could be because of the
increased chain interpenetration and/or increased crosslinking between chains. Because the PEGMA
monomers are amphiphilic, they can most likely penetrate deeper into the hydrophobic PDEAEMA cores
than the charged shell monomers. Because we also added extra crosslinker during the shell synthesis,
the crosslinking PEGMA chains deeper within the particles could limit the degree of swelling.
The zeta potentials were measured by DLS in 5 mM NaCI solutions with various pHs and were
nearly identical for each of the nanoparticles even though their shells had different charges (Figure 7B).
The zeta potentials changed from about +50 my to about -50 my across a pH range of 5 - 10 with an
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isoelectric point at about pH 9 for each sample. If we assume that we were successful in polymerizing
the nanoparticles with shells of different charges, then this suggests that the shells have an insignificant
effect on the distribution of ions surrounding the particle surface. This would imply that the zeta-
potential measured for each sample reflects the charge density of the inner PDEAEMA core instead of
the different shell layers, which seems reasonable when you consider how the PDEAEMA core comprises
such a larger volume compared to the thin shell layers. The isoelectric point at pH 9 suggests that the
observed zeta potentials reflect the PDEAEMA core because at that pH we would expect nearly all of the
of the tertiary amines from the DEAEMA monomer (pKb 7.0-7.3) to be uncharged. An important
consequence from this observation is that the addition of the MAA/PEGMA shell probably would not
allow the core-shell nanoparticles to adsorb positively charged drugs.
To test the hypothesis that the shells had no affect on the zeta potential due to the relative sizes
of the cores and shells, we synthesized another set of nanoparticles in which we attempted to reduce
the size of the PDEAEMA core and increase the thickness of the PAEMA shell. To reduce the core
thickness, we used half the weight of the DEAEMA monomer, PEGDMA crosslinker, and APS initiator
compared to the amounts used by Hu et al. (2007), and we let the synthesis run for only 1 hour. For a
thicker shell, we added 4.5x the normal weight of AEMA with 0.5 mol% of PEGDMA. Figure 8 shows the
zeta potentials measured using DLS in in 5 mM NaCI solutions with varying pHs for the particles with
different PAEMA shell thicknesses.
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Figure 8. pH-responsive zeta potential of nanoparticles with AEMA shells of different thicknesses. The thick AEMA
shell particles was synthesized using half the reagent concentrations for the PDEAEMA core and 4.5 x the weight of
AEMA (180 mg)synthesized Zeta potential was measured using DLS in 5 mM NaCl solutions with various pHs
adjusted by 1 M NaOH and 1 M HCI.
Although we did not confirm that the relative thickness of the cores and shells were actually
changed, we did observe a increase in the maximum zeta potential and the isoelectric point for the
particles with the thicker PAEMA shell compared to the particles synthesized following Hu et al. (2007)'s
procedures. The maximum zeta potential was 60 mV and the isoelectric point was at ~ pH 10 for the
particles with thicker shells. The shift toward a larger positive zeta potential and a higher pH isoelectric
point is consistent with an increase in the relative amount of PAEMA compared to PDEAEMA. The zeta
potential most likely increased at the acidic pH because the PAEMA is does not exhibit pH dependent
swelling; therefore, PAEMA maintains a higher positive charge density in acidic environments compared
to the PDEAEMA. The higher pH isoelectric point is most likely due to the increase in the relative
amount of the primary amines (pKb ~ 11) in the AEMA monomer, which remain charged at higher pHs
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compared to the DEAEMA monomers. These observations support our hypothesis that we couldn't
observe any changes in the potentials from the different shell charges because we synthesized relatively
thin shells. The adsorption of positively charged drugs on a negatively charged shell still doesn't look
promising because the negative shell would have to be thick enough to overcome the positive charge
associated with the PDEAEMA core.
Future studies would include measuring the drug binding capacity of the particles with the
different charged shells with different thicknesses to see if there is any difference in the amount of
fluorescent OVA that binds to the particles. In addition, cell culture experiments involving incubation of
DCs with calcein and the particles with different shells to see if the different shell charges affects the
endosome-disrupting capacity of the nanoparticles.
Conclusion
The pH-responsive PDEAEMA-core/PAEMA-shell nanoparticles have the potential to be a powerful
tool in the development of new treatments for a variety of diseases. In particular, their ability to
facilitate efficient cytosolic drug delivery would be particularly beneficial for transcutaneous
administration of vaccines because of the efficient antigen uptake by Langheran dendritic cells.10
Therefore, we set out to synthesize smaller core-shell nanoparticles to see if we could increase their
ability to permeate into the skin. We focused on reducing the diameter of the PDEAEMA core without
the PAEMA shell because the core provides the most significant contribution to the particle diameter.
We were able to observe a decrease in particle size when we decreased the synthesis duration and
monomer concentration; however, our particles were typically larger than the particles reported by Hu
et al. (2007). Thus, we were not able to decrease the particle diameter significantly; the smallest
particle diameter we observed was 141.2 ± 0.9 nm for the "3 min synthesis at pH 8.17 whereas the
smallest particle diameter reported by Hu et al (2007) was 205 ± 5 nm. The manipulation of the
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polymerization kinetics might not be the best approach for obtaining significantly smaller particles
because they become colloidally unstable. Because the smaller particles have less of a surface charge,
the small particles most likely require another mechanism for particle stabilization rather than just
electrostatic repulsion. When we created PDEAEMA/PEGMA copolymer nanoparticles, we observed
slightly smaller particles. Changing the polymerization kinetics and the relative monomer fraction could
allow us to produce smaller particles because the amphiphilic copolymer also provides steric
stabilization. Because the drugs are electrostatically adsorbed to the particle surface, the shell
composition was believed to be critical in determining type of drugs that can be chaperoned by the
core-shell nanoparticles. Therefore, we wanted to observe the flexibility in the shell composition to see
whether the nanoparticles could be tailored towards a variety of potential drugs. We synthesized three
sets of nanoparticles with different shell compositions: polar PEGMA, negatively charged MAA/PEGMA
shell, and a positively charged AEMA/PEGMA shell. Surprisingly, the particles with the different charged
shells all exhibited similar zeta potentials, which mostly reflected the surface charge density of the
PDEAEMA core. When we synthesized nanoparticles with a smaller PDEAEMA core and a thicker PAEMA
shell, we were able to observe a change in the zeta potential that was consistent with the larger positive
surface charge density and the higher pKb of the PAEMA shell. This suggests that the adsorption of
positively charged drugs may be difficult because it would require negatively charged shell that is thick
enough to counteract the positive PDEAEMA core.
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